This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2021 Jun;594(7862):161-162.

doi: 10.1038/d41586-021-01497-8.

WHO approval of Chinese CoronaVac COVID vaccine will be crucial to curbing pandemic

Smriti Mallapaty

PMID: 34089030
DOI: 10.1038/d41586-021-01497-8

WHO approval of Chinese CoronaVac COVID vaccine will be crucial to curbing pandemic

Smriti Mallapaty. Nature. 2021 Jun.

. 2021 Jun;594(7862):161-162.

doi: 10.1038/d41586-021-01497-8.

Author

Smriti Mallapaty

PMID: 34089030
DOI: 10.1038/d41586-021-01497-8

No abstract available

Keywords: Diseases; SARS-CoV-2; Vaccines.

PubMed Disclaimer

Similar articles

China's COVID vaccines are going global - but questions remain.
Mallapaty S. Mallapaty S. Nature. 2021 May;593(7858):178-179. doi: 10.1038/d41586-021-01146-0. Nature. 2021. PMID: 33948031 No abstract available.
Molecular deconvolution of the neutralizing antibodies induced by an inactivated SARS-CoV-2 virus vaccine.
Zhou X, Wang H, Ji Q, Du M, Liang Y, Li H, Li F, Shang H, Zhu X, Wang W, Jiang L, Stepanov AV, Ma T, Gong N, Jia X, Gabibov AG, Lou Z, Lu Y, Guo Y, Zhang H, Yang X. Zhou X, et al. Protein Cell. 2021 Oct;12(10):818-823. doi: 10.1007/s13238-021-00840-z. Epub 2021 Apr 28. Protein Cell. 2021. PMID: 33909239 Free PMC article. No abstract available.
China's COVID vaccines have been crucial - now immunity is waning.
Mallapaty S. Mallapaty S. Nature. 2021 Oct;598(7881):398-399. doi: 10.1038/d41586-021-02796-w. Nature. 2021. PMID: 34650240 No abstract available.
Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update.
Anand U, Jakhmola S, Indari O, Jha HC, Chen ZS, Tripathi V, Pérez de la Lastra JM. Anand U, et al. Front Immunol. 2021 Jun 30;12:658519. doi: 10.3389/fimmu.2021.658519. eCollection 2021. Front Immunol. 2021. PMID: 34276652 Free PMC article. Review.
The granting of emergency use designation to COVID-19 candidate vaccines: implications for COVID-19 vaccine trials.
Singh JA, Upshur REG. Singh JA, et al. Lancet Infect Dis. 2021 Apr;21(4):e103-e109. doi: 10.1016/S1473-3099(20)30923-3. Epub 2020 Dec 8. Lancet Infect Dis. 2021. PMID: 33306980 Free PMC article. Review.

See all similar articles

Cited by

A randomized clinical trial of a booster dose with low versus standard dose of AZD1222 in adult after 2 doses of inactivated vaccines.
Nanthapisal S, Puthanakit T, Jaru-Ampornpan P, Nantanee R, Sodsai P, Himananto O, Sophonphan J, Suchartlikitwong P, Hiransuthikul N, Angkasekwinai P, Tangsathapornpong A, Hirankarn N; study team. Nanthapisal S, et al. Vaccine. 2022 Apr 20;40(18):2551-2560. doi: 10.1016/j.vaccine.2022.03.036. Epub 2022 Mar 24. Vaccine. 2022. PMID: 35341647 Free PMC article. Clinical Trial.
Vaccines for COVID-19: A Systematic Review of Immunogenicity, Current Development, and Future Prospects.
Zhang Z, Shen Q, Chang H. Zhang Z, et al. Front Immunol. 2022 Apr 27;13:843928. doi: 10.3389/fimmu.2022.843928. eCollection 2022. Front Immunol. 2022. PMID: 35572592 Free PMC article.
Humoral immunity and transcriptome differences of COVID-19 inactivated vacciane and protein subunit vaccine as third booster dose in human.
Zhang Y, Yao M, Guo X, Han S, Zhang S, Zhang J, Jiang X, Wang J, Fang M, Wang S, Pang B, Liu X, Kou Z, Jiang X. Zhang Y, et al. Front Immunol. 2022 Oct 21;13:1027180. doi: 10.3389/fimmu.2022.1027180. eCollection 2022. Front Immunol. 2022. PMID: 36341453 Free PMC article.
Immune Evasive Effects of SARS-CoV-2 Variants to COVID-19 Emergency Used Vaccines.
Zhang Y, Banga Ndzouboukou JL, Gan M, Lin X, Fan X. Zhang Y, et al. Front Immunol. 2021 Nov 22;12:771242. doi: 10.3389/fimmu.2021.771242. eCollection 2021. Front Immunol. 2021. PMID: 34880867 Free PMC article. Review.
Factors Influencing Vaccine Hesitancy in China: A Qualitative Study.
Wang J, Ji Q, Dong S, Zhao S, Li X, Zhu Q, Long S, Zhang J, Jin H. Wang J, et al. Vaccines (Basel). 2021 Nov 7;9(11):1291. doi: 10.3390/vaccines9111291. Vaccines (Basel). 2021. PMID: 34835221 Free PMC article.

See all "Cited by" articles

References

1. Palacios, R. et al. Preprint at SSRN https://doi.org/10.2139/ssrn.3822780 (2021).

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal